241 related articles for article (PubMed ID: 30915635)
1. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
[TBL] [Abstract][Full Text] [Related]
4. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
[TBL] [Abstract][Full Text] [Related]
5. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
Raffone A; Travaglino A; Saccone G; Cieri M; Mascolo M; Mollo A; Insabato L; Zullo F
APMIS; 2019 Sep; 127(9):597-606. PubMed ID: 31237034
[TBL] [Abstract][Full Text] [Related]
7. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
[TBL] [Abstract][Full Text] [Related]
8. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F
APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040
[TBL] [Abstract][Full Text] [Related]
9. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
10. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
[TBL] [Abstract][Full Text] [Related]
11. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
13. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
14. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
[TBL] [Abstract][Full Text] [Related]
15. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
[TBL] [Abstract][Full Text] [Related]
16. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
[TBL] [Abstract][Full Text] [Related]
17. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
[TBL] [Abstract][Full Text] [Related]
19. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
20. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
